Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMineral & Financial Investments Regulatory News (MAFL)

Share Price Information for Mineral & Financial Investments (MAFL)

Share Price is delayed by 15 minutes
Get Live Data
47.50    -0.50 (-1.04%)
Bid:
47.00
Ask:
48.00
Spread: 1.00 (2.128%)
Market Cap: £18.46m
MAFL Live PriceLast checked at - London Stock Exchange

Intraday Mineral & Financial Investments Share Chart

Holding(s) in Company

25 Jul 2013 07:00

RNS Number : 0957K
Mineral & Financial Invest. Limited
25 July 2013
 



 

For For filings with the FCA include the annex
 
For For filings with issuer exclude the annex
 
 
TR TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Mineral and Financial Investments Limited

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Webb Capital Asset Management Limited

4. Full name of shareholder(s)  (if different from 3.):iv

BNP Paribas Securities Services

 

a/c SF Webb Capital Smaller Companies Gold Fund

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

24/07/2013

6. Date on which issuer notified:

24/07/2013

7. Threshold(s) that is/are crossed orreached: vi, vii

Below 3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary 1p

 

2,626,371

2,626,371

0

0

0%

KYG6181G1055

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

0

0%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Peter Webb

15. Contact telephone number:

020 7634 9510

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLRIMPTMBTTBTJ
Date   Source Headline
28th May 20269:22 amRNSHolding(s) in Company
18th Mar 20267:00 amRNSInterim Results
30th Jan 20263:09 pmRNSConversion Of Vested RSUs into Ordinary Shares
28th Jan 20267:00 amRNSHolding(s) in Company
27th Jan 202611:38 amRNSHolding(s) in Company
20th Jan 20261:06 pmRNSResult of AGM
20th Jan 20267:00 amRNS1st Quarter Results
22nd Dec 20257:00 amRNSAudited Results for Year Ended 30 June 2025
22nd Dec 20257:00 amRNSAudited Results for Year Ended 30 June 2025
7th Oct 20252:35 pmRNSDirector/PDMR Shareholding
20th Aug 20258:45 amRNSGrant of RSU's and Exercise of Options
14th Jul 202511:22 amRNSUpdate on Redcorp's Lagoa Salgada EIA Application
12th Jun 20256:18 pmRNSHolding(s) in Company
6th Jun 20259:39 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSUnaudited Quarterly Results
22nd May 20255:28 pmRNSDirector/PDMR Shareholding
7th May 20255:21 pmRNSDirector/PDMR Shareholding
7th May 20254:26 pmRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSIssue of Equity
20th Mar 20255:13 pmRNSInvestment in Physical Silver
20th Mar 20257:00 amRNSInterim Results for Six Months Ended 31 Dec 24
7th Mar 202511:45 amRNSHolding(s) in Company
4th Feb 20257:00 amRNSInvestment Update: Ascendant
22nd Jan 202512:20 pmRNSDirector/PDMR Shareholding
16th Jan 20251:24 pmRNSReplacement: Unaudited Quarterly Net Asset Value
16th Jan 20257:00 amRNSUnaudited Quarterly Net Asset Value
18th Dec 20242:52 pmRNSResult of AGM
11th Dec 202411:05 amRNSInvestment Update: Ascendant / Redcorp
25th Nov 20242:37 pmRNSHolding(s) in Company
19th Nov 20245:53 pmRNSAudited Results for Year Ended 30 June 2024
1st Nov 202411:03 amRNSInvestment Update: Ascendant / Redcorp
15th Oct 202411:00 amRNSInvestment Update: Redcorp
30th Sep 202411:00 amRNSInvestment Update: Ascendant / Redcorp
19th Sep 20247:00 amRNSInvestment Update: Ascendant / Redcorp
17th Jul 20247:00 amRNSInvestment Update: Redcorp
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
12th Jul 20247:00 amRNSDirector Update
13th Jun 20247:00 amRNSUnaudited Quarterly Net Asset Value
29th Apr 20247:00 amRNSDirector Dealing
10th Apr 20244:22 pmRNSHolding(s) in Company
10th Apr 202411:00 amRNSInvestment Update: Ascendant / Redcorp
27th Mar 20247:00 amRNSInterim Results for Six Months Ended 31 Dec 23
29th Feb 20241:01 pmRNSCorrection - Investment Update: Ascendant /Redcorp
29th Feb 20247:00 amRNSInvestment Update: Ascendant / Redcorp
5th Feb 20247:00 amRNSUnaudited Quarterly Net Asset Value
31st Jan 20246:04 pmRNSResult of AGM
8th Jan 20247:00 amRNSDirector Dealing
3rd Jan 202411:00 amRNSInvestment Update: Ascendant / Redcorp
28th Dec 20232:29 pmRNSNotice of AGM and Posting of Annual Report
20th Dec 20235:25 pmRNSAudited Results for Year Ended 30 June 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.